Results 241 to 250 of about 508,157 (387)
What's New? Little is known about how genetic variation in human papillomavirus type 45 (HPV45) influences its ability to cause cancer. Here, the authors conducted the largest whole‐genome sequencing study to date of HPV45, looking for associations between viral genetic variation and precancer or cancer risk.
Aimee J. Koestler+14 more
wiley +1 more source
PRESENT POSITION OF CAESAREAN SECTION IN OBSTETRIC PRACTICE [PDF]
J. Bright Banister
openalex +1 more source
What's New? Immunohistochemical biomarkers are increasingly used for the grading of cervical intraepithelial neoplasia (CIN); however, their clinical utility in the prediction of CIN2 regression is largely unexplored. Here, the authors analyzed the risk of CIN2 regression in relation to p16INK4a and HPVE4 immunohistochemistry in a large cohort of women
Rikke Damgaard+10 more
wiley +1 more source
Emerging human rights standards on obstetric violence and abuse during childbirth. [PDF]
Pickles C.
europepmc +1 more source
What's New? Vaginal high‐grade squamous intraepithelial lesions (HSILs), precursors of vaginal cancer that are related to human papillomavirus (HPV) infection, often are treated with laser vaporization. HSIL treated in this way, however, tends to recur.
Mari Kiviharju+7 more
wiley +1 more source
The Obstetrical Society of London and the Midwives Question: Being an Abstract of the Inaugural Address delivered before the Society on March 6th, 1895 [PDF]
Francis Henry Champneys
openalex +1 more source
What's New? Circulating tumor cells can offer insights into treatment responses and metastatic recurrence, but current analysis methods are limited. Here, the authors tested a newly developed mass cytometry panel comprising biomarkers such as γH2AX and RAD51 in longitudinally monitored metastatic breast cancer patients.
Kathrin Niedermayer+17 more
wiley +1 more source
Acute obstetric coagulopathy: need for innovation. [PDF]
Chumappumkal Joseph B, von Drygalski A.
europepmc +1 more source